The number of individuals being tested for hereditary cancer syndromes has greatly increased in the last several years and many people receive Variants of Uncertain Significance (VUS) as a test result. Although VUS results should not guide medical management, patients and even some healthcare providers continue to use a VUS to alter or receive unnecessary medical care. We conducted a needs assessment via literature review and analyzed VUS patient interviews from a previous study with the goal of identifying various themes that could help determine content, layout, and messaging to incorporate into online educational materials. The needs assessment found few educational materials and identified the following themes: people may take inappropr...
BACKGROUND Nearly 15% of BRCA1 and BRCA2 DNA tests lead to the identification of Variants of Uncerta...
Background: Many clients who undergo genetic testing (GT) for cancer risk assessment receive variant...
Increased insight into the information needs of people about cancer genetic predisposition could all...
The number of individuals being tested for hereditary cancer syndromes has greatly increased in the ...
As genomic sequencing expands into more areas of patient care, an increasing number of patients lear...
Thesis (Ph.D.)--University of Washington, 2018The overall aim of this dissertation was to study how ...
Establishing a genetic diagnosis may lead to major health benefits for the patient and their wider f...
Background: The use of multigene panel testing for identifying individuals with hereditary cancer su...
Reducing cancer-related uncertainty is a motivating factor for accessing genetic testing, such as te...
Despite national guidelines, women with a BRCA VUS or CHEK2 pathogenic variant are choosing to have ...
Multigene panel testing is mainly used to improve identification of genetic causes in families with ...
Objective: Cancer genetic counseling increasingly involves discussing uncertain test results, for ex...
Multigene panel testing is mainly used to improve identification of genetic causes in families with ...
Contains fulltext : 142762.pdf (publisher's version ) (Open Access)Approximately 5...
Pathogenic variants (PV) or likely pathogenic variants (LPV) in a cancer risk gene increase lifetime...
BACKGROUND Nearly 15% of BRCA1 and BRCA2 DNA tests lead to the identification of Variants of Uncerta...
Background: Many clients who undergo genetic testing (GT) for cancer risk assessment receive variant...
Increased insight into the information needs of people about cancer genetic predisposition could all...
The number of individuals being tested for hereditary cancer syndromes has greatly increased in the ...
As genomic sequencing expands into more areas of patient care, an increasing number of patients lear...
Thesis (Ph.D.)--University of Washington, 2018The overall aim of this dissertation was to study how ...
Establishing a genetic diagnosis may lead to major health benefits for the patient and their wider f...
Background: The use of multigene panel testing for identifying individuals with hereditary cancer su...
Reducing cancer-related uncertainty is a motivating factor for accessing genetic testing, such as te...
Despite national guidelines, women with a BRCA VUS or CHEK2 pathogenic variant are choosing to have ...
Multigene panel testing is mainly used to improve identification of genetic causes in families with ...
Objective: Cancer genetic counseling increasingly involves discussing uncertain test results, for ex...
Multigene panel testing is mainly used to improve identification of genetic causes in families with ...
Contains fulltext : 142762.pdf (publisher's version ) (Open Access)Approximately 5...
Pathogenic variants (PV) or likely pathogenic variants (LPV) in a cancer risk gene increase lifetime...
BACKGROUND Nearly 15% of BRCA1 and BRCA2 DNA tests lead to the identification of Variants of Uncerta...
Background: Many clients who undergo genetic testing (GT) for cancer risk assessment receive variant...
Increased insight into the information needs of people about cancer genetic predisposition could all...